U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3003130031Chronic Pain and Social Vulnerability: Prevalence and Predictive Factors of the Social Vulnerability in Evaluation and Treatment of the Pain Center (CETD)RecruitingNo Results AvailableChronic PainOther: Questionnaire EPICES (Evaluation of the Precariousness and the Disparities of Health for the Centers of Examination of Health).https://ClinicalTrials.gov/show/NCT02171936
3003230032Multicenter Comparative Study of the Activity of the Medial Prefrontal Cortex in Vulnerability to DepressionActive, not recruitingNo Results AvailableMajor Depressionhttps://ClinicalTrials.gov/show/NCT02171923
3003330033Doxapram as an Additive to Propofol Sedation in Sedation for ERCPNot yet recruitingNo Results AvailableSedation|HypoxiaDrug: Doxapram|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02171910
3003430034Pertrochanter Arthroplasty Versus OsteosynthesisNot yet recruitingNo Results AvailablePertrochanter FractureProcedure: Osteosynthesis|Procedure: Total hip replacementhttps://ClinicalTrials.gov/show/NCT02171897
3003530035Study of the Impact of Freezing-thawing Procedures and the Prolonged Culture of Embryos on Epigenetic Regulation in HumansRecruitingNo Results AvailableAssisted Reproductive Technology|Freezing/Thawing Procedure|Prolonged Culture ProcedureOther: Sample of cord blood|Other: Sample of placentahttps://ClinicalTrials.gov/show/NCT02171884
3003630036Effects Of Passive Smoking On The Respiratory System Mechanics Of Healthy Non-Smokers In Different Body PositionsCompletedNo Results AvailablePASSIVE SMOKING ,|RESPIRATORY SYSTEM MECHANICS,Other: exposed to a smoking environmenthttps://ClinicalTrials.gov/show/NCT02171871
3003730037Multivariate Analysis of Serum High Sensitivity C-Reactive Protein in Patients With Acute Phase StrokeEnrolling by invitationNo Results AvailableStroke|National Institutes of Health Stroke Scale|Serum High Sensitivity C-Reactive Proteinhttps://ClinicalTrials.gov/show/NCT02171858
3003830038Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in HumansRecruitingNo Results AvailableMedical Termination of Pregnancy|Voluntary Termination of PregnancyOther: surgical biopsieshttps://ClinicalTrials.gov/show/NCT02171845
3003930039Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionCompletedNo Results AvailableHealthy|Liver DiseasesDrug: BI 1744 CL, low dose|Drug: BI 1744 CL, high dosehttps://ClinicalTrials.gov/show/NCT02171832
3004030040Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1CompletedNo Results AvailableInfluenza A Subtype H5N1 InfectionBiological: IVACFLU-A/H5N1, 7.5 mcg|Biological: Experimental: IVACFLU-A/H5N1, 15 mcghttps://ClinicalTrials.gov/show/NCT02171819
3004130041Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BI 1744 CL in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: BI 1744 CL|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02171806
3004230042Single Rising Peroral Doses of BI 1744 CL in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: BI 1744 CL|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02171793
3004330043A Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 1744 CL in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: BI 1744 CL|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02171780
3004430044Safety and Tolerability of 4 Different Dosage Strengths of BIBW 2992 Tablets to Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BIBW 2992 MA2 - single rising dosehttps://ClinicalTrials.gov/show/NCT02171767
3004530045Relative Bioavailability of a Single-dose Administration of BIBW 2992 and Multiple-dose Administration of Ritonavir in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: BIBW 2992|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT02171754
3004630046Dose Escalation Trial of BIBW 2992 Administration in Combination With Docetaxel in Patients With Advanced Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: BIBW 2992|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT02171741
3004730047Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: BIBW 2992https://ClinicalTrials.gov/show/NCT02171728
3004830048BIBW 2992 Administered as Tablet (Final Formulation) Compared to BIBW 2992 Drinking Solution and BIBW 2992 Tablet (Trial Formulation II) in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BIBW 2992 MA2|Drug: BIBW 2992 MA2|Drug: BIBW 2992 MA2https://ClinicalTrials.gov/show/NCT02171715
3004930049Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid TumoursCompletedNo Results AvailableNeoplasmsDrug: BIBW 2992https://ClinicalTrials.gov/show/NCT02171702
3005030050Metabolism and Pharmacokinetics of [14C]- BIBW 2992 MA2 in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: [14C]- BIBW 2992 MA2https://ClinicalTrials.gov/show/NCT02171689
3005130051BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: Docetaxel|Drug: BIBW 2992https://ClinicalTrials.gov/show/NCT02171676
3005230052Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: BIBW 2992https://ClinicalTrials.gov/show/NCT02171663
3005330053BIBW 2992 in Patients With Advanced Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: BIBW 2992https://ClinicalTrials.gov/show/NCT02171650
3005430054Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: BIBW 2992https://ClinicalTrials.gov/show/NCT02171637
3005530055Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran EtexilateCompletedNo Results AvailableHealthyDrug: dabigatran etexilate|Drug: quinidinehttps://ClinicalTrials.gov/show/NCT02171624
3005630056Bioavailability of Different Applications of Dabigatran in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Dabigatran etexilate pellets|Drug: Dabigatran etexilate powder|Drug: Dabigatran etexilate capsulehttps://ClinicalTrials.gov/show/NCT02171611
3005730057Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male SubjectsCompletedNo Results AvailableHealthyDrug: Clopidogrel|Drug: Dabigatran high dose|Drug: Dabigatran low dosehttps://ClinicalTrials.gov/show/NCT02171598
3005830058Bioavailability of Dabigatran With or Without Clarithromycin in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Dabigatran etexilate|Drug: Clarithromycinhttps://ClinicalTrials.gov/show/NCT02171585
3005930059Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese SubjectsCompletedNo Results AvailableHealthyDrug: Dabigatran etexilate low|Drug: Dabigatran etexilate highhttps://ClinicalTrials.gov/show/NCT02171572
3006030060Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Enoxaparin prefilled syringes|Drug: Dabigatran etexilate capsuleshttps://ClinicalTrials.gov/show/NCT02171559

* Görseller ve İçerik tekif hakkına sahip olabilir